Parametric Portfolio Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$306K Buy
131,423
+31,149
+31% +$97.2K ﹤0.01% 3267
2021
Q4
$466K Sell
100,274
-1,642
-2% -$10.2K ﹤0.01% 3103
2021
Q3
$778K Sell
101,916
-39,223
-28% -$333K ﹤0.01% 2907
2021
Q2
$1.37M Buy
141,139
+8,251
+6% +$65.7K ﹤0.01% 2638
2021
Q1
$1.1M Buy
132,888
+23,331
+21% +$246K ﹤0.01% 3123
2020
Q4
$748K Buy
109,557
+57,213
+109% +$460K ﹤0.01% 3192
2020
Q3
$584K Buy
52,344
+7,106
+16% +$65K ﹤0.01% 3197
2020
Q2
$284K Buy
45,238
+17,060
+61% +$65.3K ﹤0.01% 3493
2020
Q1
$52K Sell
28,178
-1,640
-6% -$4.72K ﹤0.01% 3833
2019
Q4
$101K Sell
29,818
-153,414
-84% -$366K ﹤0.01% 3859
2019
Q3
$392K Sell
183,232
-129,174
-41% -$301K ﹤0.01% 3428
2019
Q2
$834K Buy
312,406
+5,608
+2% +$20.2K ﹤0.01% 3142
2019
Q1
$1.46M Buy
+306,798
New +$805K ﹤0.01% 2832
2018
Q4
Sell
-20,500
Closed -$90K 3983
2018
Q3
$90K Sell
20,500
-33,077
-62% -$183K ﹤0.01% 3857
2018
Q2
$386K Buy
+53,577
New +$364K ﹤0.01% 3454
2015
Q3
Sell
-10,430
Closed -$184K 3355
2015
Q2
$184K Buy
+10,430
New +$134K ﹤0.01% 3787

Other funds holding SRNE